A Phase I/II study of vesigenurtacel-l (hs-410) or placebo in combination with Bacillus Calmette-Guérin (BCG) in patients with non-muscle invasive bladder cancer (NMIBC)

Detalles Bibliográficos
Autores principales: Steinberg, Gary D, Shore, Neal, Karsh, Lawrence, Bailen, James, Woods, Michael, Schoenberg, Mark, Schreiber, Taylor H, Price, Melissa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Poster Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288751/
http://dx.doi.org/10.1186/2051-1426-2-S3-P81

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288751/
http://dx.doi.org/10.1186/2051-1426-2-S3-P81

Ejemplares similares